Impact of mass drug administration for elimination of lymphatic filariasis in Nepal
Open Access
- 19 July 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 11 (7) , e0005788
Abstract
Lymphatic filariasis (LF) is a neglected tropical disease transmitted by mosquitoes. Nepal has implemented a national effort to eliminate LF by 2020 through mass drug administration (MDA) using diethylcarbamazine (DEC) and albendazole (ALB). We assessed the impact of MDAs on LF in selected districts of Nepal after the recommended six MDA rounds had been completed. Baseline surveys were conducted in seven districts and mapping data were used as baseline in the other three districts before starting MDA in 2009. LF antigen (Ag) prevalence ranged from 1.06% to 20% among districts included in the baseline and mapping study. The number of people who received DEC and ALB were recorded during each MDA round and population-based cluster surveys were conducted at least once in each district during the life of the program. The reported MDA coverage in five districts was consistently at least 65%. Two districts achieved the targeted coverage in four out of five rounds and the rest three districts achieved the target only in the first round. A pre-transmission assessment survey (pre-TAS) was conducted in one sentinel site and at least one spot check site in each of the districts after five MDA rounds. In pre-TAS, all the sites of five districts (Pyuthan, Arghakhanchi, Kaski, Bhaktapur, and Kathmandu) and all but one spot check site of Lalitpur district had LF Ag < 2% (ranging from 0.0% to 1.99%). Transmission assessment survey (TAS) was conducted in six evaluation units (EUs) consisting of six districts qualified on pre-TAS. Though MDA coverage of 65% was not achieved in three districts (Kathmandu, Lalitpur and Bhaktapur), Nepal government in consultation with World Health Organization (WHO) decided to conduct TAS. All six EUs achieved the LF Ag threshold required to stop MDA in TAS, despite the low reported MDA coverage in those three districts. Although Nepal has achieved significant progress towards LF elimination, five rounds of MDA were not sufficient to disrupt the transmission cycle in all districts, probably because of high baseline prevalence. Lymphatic filariasis (LF) is a deforming and disabling infectious disease manifested in the form of elephantiasis and hydroceles. Based on mapping data, 61 out of 75 districts of Nepal were found to be endemic for LF and mass drug administration (MDA) of diethylcarbamazine and albendazole has been already started in 56 districts. The objective of MDA is to interrupt transmission of Wuchereria bancrofti in LF endemic districts. In 2015, ten districts had completed six MDA rounds. In this study we reported the impact of the national LF elimination effort in these ten districts of Nepal. The reported coverage rate in each MDA round was consistently above 65% in five districts. Compared to the baseline surveys, pre-transmission assessment surveys (pre-TAS) conducted after completion of five MDA rounds showed reductions in LF antigenemia (Ag) in most districts. Six out of ten districts (formed into six evaluation units) were eligible for TAS, which showed LF Ag below the cutoff point in all six EUs, suggesting successful interruption of LF transmission in six out of ten districts after six MDA rounds.Keywords
Funding Information
- RTI International Nepal
This publication has 27 references indexed in Scilit:
- Insights into the Pathogenesis of Disease in Human Lymphatic FilariasisLymphatic Research and Biology, 2013
- Urban lymphatic filariasisParasitology Research, 2012
- Epidemiological Assessment of Eight Rounds of Mass Drug Administration for Lymphatic Filariasis in India: Implications for Monitoring and EvaluationPLOS Neglected Tropical Diseases, 2012
- Coverage and compliance MDA programme for lymphatic filariasis in Bidar district, Karnataka, IndiaAsian Pacific Journal of Tropical Disease, 2012
- Coverage and compliance to mass drug administration for lymphatic filariasis elimination in a district of Kerala, IndiaInternational Health, 2011
- A Community-Based Study of Factors Associated with Continuing Transmission of Lymphatic Filariasis in Leogane, HaitiPLOS Neglected Tropical Diseases, 2010
- The Impact of Repeated Rounds of Mass Drug Administration with Diethylcarbamazine Plus Albendazole on Bancroftian Filariasis in Papua New GuineaPLOS Neglected Tropical Diseases, 2008
- The Global Programme to Eliminate Lymphatic Filariasis: Health Impact after 8 YearsPLOS Neglected Tropical Diseases, 2008
- Factors associated with the acceptance of mass drug administration for the elimination of lymphatic filariasis in Agusan del Sur, PhilippinesParasites & Vectors, 2008
- Filariasis: nutritional interactions in human and animal hostsParasitology, 1993